Published in Hypertension on April 01, 2005
Age and the difference between awake ambulatory blood pressure and office blood pressure: a meta-analysis. Blood Press Monit (2011) 0.87
Discrepancies in office and ambulatory blood pressure in adolescents: help or hindrance? Pediatr Nephrol (2007) 0.75
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet (2010) 8.39
Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet (2007) 5.21
Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension (2005) 5.05
Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med (2003) 4.59
Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol (2010) 3.93
Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study. Hypertension (2006) 3.42
European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens (2008) 3.32
Masked hypertension in diabetes mellitus: treatment implications for clinical practice. Hypertension (2013) 2.89
Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension (2010) 2.64
Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA). Diabetes Care (2005) 2.59
Ambulatory blood pressure monitoring in 9357 subjects from 11 populations highlights missed opportunities for cardiovascular prevention in women. Hypertension (2011) 2.33
Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens (2010) 2.28
Ambulatory arterial stiffness index derived from 24-hour ambulatory blood pressure monitoring. Hypertension (2006) 2.19
Making ambulatory blood pressure monitoring accessible in pharmacies. Blood Press Monit (2014) 1.95
Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial. J Hypertens (2004) 1.87
Blood pressure and urinary sodium in men and women: the Norfolk Cohort of the European Prospective Investigation into Cancer (EPIC-Norfolk). Am J Clin Nutr (2004) 1.86
Self-measured versus ambulatory blood pressure in the diagnosis of hypertension. J Hypertens (2003) 1.78
Structure-based design of aliskiren, a novel orally effective renin inhibitor. Biochem Biophys Res Commun (2003) 1.74
The International Database of Ambulatory Blood Pressure in relation to Cardiovascular Outcome (IDACO): protocol and research perspectives. Blood Press Monit (2007) 1.62
The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes. J Hypertens (2008) 1.61
A new solar-powered blood pressure measuring device for low-resource settings. Hypertension (2010) 1.61
European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens (2014) 1.58
Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial. Eur Heart J (2006) 1.58
Blood pressure variability: clarity for clinical practice. Hypertension (2010) 1.55
Outcome-driven thresholds for ambulatory pulse pressure in 9938 participants recruited from 11 populations. Hypertension (2013) 1.50
Impact of applying the more stringent validation criteria of the revised European Society of Hypertension International Protocol 2010 on earlier validation studies. Blood Press Monit (2011) 1.50
Risk stratification by 24-hour ambulatory blood pressure and estimated glomerular filtration rate in 5322 subjects from 11 populations. Hypertension (2012) 1.49
Determinants of the ambulatory arterial stiffness index in 7604 subjects from 6 populations. Hypertension (2008) 1.48
Responses of the ambulatory arterial stiffness index and other measures of arterial function to antihypertensive drugs. Hypertens Res (2011) 1.47
Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren. Hypertension (2003) 1.46
Blood pressure load does not add to ambulatory blood pressure level for cardiovascular risk stratification. Hypertension (2014) 1.44
Night-time blood pressure and target organ damage: a comparative analysis of absolute blood pressure and dipping status. J Hypertens (2015) 1.41
White-coat hypertension: new insights from recent studies. Hypertension (2013) 1.39
Tissue Doppler E/E' ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT substudy. Eur Heart J (2009) 1.30
Ambulatory arterial stiffness index and 24-hour ambulatory pulse pressure as predictors of mortality in Ohasama, Japan. Stroke (2007) 1.25
Quality control of the blood pressure phenotype in the European Project on Genes in Hypertension. Blood Press Monit (2002) 1.21
Self monitoring of blood pressure at home. BMJ (2004) 1.14
Cardiovascular risk assessment in low-resource settings: a consensus document of the European Society of Hypertension Working Group on Hypertension and Cardiovascular Risk in Low Resource Settings. J Hypertens (2014) 1.04
When can the practicing physician suspect white coat hypertension? Statement from the Working Group on Blood Pressure Monitoring of the European Society of Hypertension. Am J Hypertens (2003) 1.04
Prognostic value of ambulatory heart rate revisited in 6928 subjects from 6 populations. Hypertension (2008) 1.00
Determinants of white-coat syndrome assessed by ambulatory blood pressure or self-measured home blood pressure. Blood Press Monit (2003) 0.97
Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy. J Hypertens (2009) 0.96
Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study. Am J Hypertens (2004) 0.96
Recommendations for blood pressure measuring devices for office/clinic use in low resource settings. Blood Press Monit (2005) 0.96
Ambulatory arterial stiffness index predicts stroke in a general population. J Hypertens (2006) 0.95
Differential effects of antihypertensive treatment on left ventricular diastolic function: an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy. J Am Coll Cardiol (2010) 0.92
Hypertension and diabetes: entry points for prevention and control of the global cardiovascular epidemic. Int J Hypertens (2013) 0.91
Ambulatory arterial stiffness index: rationale and methodology. Blood Press Monit (2006) 0.91
[ESH/ESC 2007 Guidelines for the management of arterial hypertension]. Rev Esp Cardiol (2007) 0.90
Ambulatory arterial stiffness index: a systematic review and meta-analysis. Atherosclerosis (2012) 0.89
Finite element analysis of vulnerable atherosclerotic plaques: a comparison of mechanical stresses within carotid plaques of acute and recently symptomatic patients with carotid artery disease. J Neurol Neurosurg Psychiatry (2009) 0.88
Short-term and long-term repeatability of the morning blood pressure in older patients with isolated systolic hypertension. J Hypertens (2008) 0.88
Polymorphisms of the Flavin containing monooxygenase 3 (FMO3) gene do not predispose to essential hypertension in Caucasians. BMC Med Genet (2005) 0.88
Hypertensive target-organ damage in the very elderly. Hypertension (2003) 0.87
Limitations of current validation protocols for home blood pressure monitors for individual patients. Blood Press Monit (2002) 0.86
Policy statement of the world hypertension league on noninvasive blood pressure measurement devices and blood pressure measurement in the clinical or community setting. J Clin Hypertens (Greenwich) (2014) 0.86
Requirements for professional office blood pressure monitors. J Hypertens (2012) 0.86
How many measurements are needed to estimate blood pressure variability without loss of prognostic information? Am J Hypertens (2013) 0.85
Dipping comes of age: the importance of nocturnal blood pressure. Hypertension (2009) 0.85
Double product reflects the predictive power of systolic pressure in the general population: evidence from 9,937 participants. Am J Hypertens (2013) 0.84
Twenty-four-hour ambulatory blood pressure in community-dwelling elderly men and women, aged 60-102 years. J Hypertens (2003) 0.84
European Society of Hypertension International Protocol for the validation of blood pressure monitors: a critical review of its application and rationale for revision. Blood Press Monit (2010) 0.84
Long-term antihypertensive treatment fails to improve E/e' despite regression of left ventricular mass: an Anglo-Scandinavian cardiac outcomes trial substudy. Hypertension (2013) 0.84
Confirmation that the renin gene distal enhancer polymorphism REN-5312C/T is associated with increased blood pressure. Circ Cardiovasc Genet (2009) 0.83
Renal denervation in treatment-resistant hypertension: the need for restraint and more and better evidence. Expert Rev Cardiovasc Ther (2013) 0.83
Relationship between ambulatory blood pressure and follow-up clinic blood pressure in elderly patients with systolic hypertension. J Hypertens (2004) 0.83
Differential effects of antihypertensive treatment on the retinal microcirculation: an anglo-scandinavian cardiac outcomes trial substudy. Hypertension (2009) 0.83
Serum amyloid A, C-reactive protein, and retinal microvascular changes in hypertensive diabetic and nondiabetic individuals: an Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) substudy. Diabetes Care (2009) 0.82
How many measurements are needed to provide reliable information in terms of the ambulatory arterial stiffness index? The Ohasama study. Hypertens Res (2010) 0.81
Ambulatory arterial stiffness index: determinants and outcome. Blood Press Monit (2006) 0.81
Morbidity and mortality on combination versus monotherapy: a posthoc analysis of the Systolic Hypertension in Europe trial. J Hypertens (2010) 0.80
Ambulatory blood pressure measurement: a trove of hidden gems? Hypertension (2006) 0.80
Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study. Am J Hypertens (2004) 0.80
Sleepers versus nonsleepers: another twist to the dipper/nondipper concept. Hypertension (2007) 0.79
The Working Group on Blood Pressure Monitoring of the European Society of Hypertension. Blood Press Monit (2003) 0.79
Effects of ramipril on arterial stiffness. Hypertension (2005) 0.78
Ambulatory blood pressure measurement as a predictor of outcome in an Irish population: methodology for ascertaining mortality outcome. Blood Press Monit (2003) 0.78
Nighttime blood pressure: a target for therapy? Curr Hypertens Rep (2010) 0.78
Lack of association between NFKBIL1/LTA polymorphisms and hypertension, myocardial infarct, unstable angina and stable angina in a large Irish population sample. Atherosclerosis (2007) 0.77
A longitudinal study of the yield and clinical utility of a specifically designed secondary hypertension investigation protocol. Ren Fail (2003) 0.77
Comparing the therapeutic merits of angiotensin receptor blockers. J Hypertens (2016) 0.77
The importance of night-time systolic blood pressure in diabetic patients: Dublin Outcome Study. J Hypertens (2015) 0.76
An endothelin antagonist for resistant hypertension. Lancet (2010) 0.75
Loss of reason. Lancet (2013) 0.75
Whither conventional blood pressure measurement? Am J Hypertens (2006) 0.75
Renal sympathetic denervation for resistant hypertension. Lancet (2009) 0.75
Thirty-minute compared to standardised office blood pressure measurement in general practice. Br J Gen Pract (2012) 0.75
Who will bell the cat? A call for a new approach for validating blood pressure measuring devices. J Hypertens (2010) 0.75
Progress in blood pressure measurement: a workshop of the European Society of Hypertension. Blood Press Monit (2007) 0.75
Spotlights on ambulatory measures of arterial stiffness. Am J Hypertens (2008) 0.75
Response to Masked hypertension in untreated and treated patients with diabetes mellitus: attractive but questionable interpretations and response to Is masked hypertension related to diabetes mellitus? Hypertension (2013) 0.75
Will generic hypertension guidelines reduce the proliferation of directives? Heart (2007) 0.75